Alerts on Instil Bio TIL.O and ImmuneOnco Biopharmaceuticals 1541.HK announcing clinical trial updates for Phase 2 trial of ‘2510 were inadvertently tagged to T Rowe Price Large-Cap Value Fund TILCX.O, an unrelated company and have been withdrawn.
For the correct set of alerts, click nFWN3RU044
STORY_NUMBER: nFWN3RU0PH
STORY_DATE: 22/05/2025
STORY_TIME: 10:01:01 GMT
((Bangalore.newsroom@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.